bupropion has been researched along with Long Sleeper Syndrome in 8 studies
Bupropion: A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.
bupropion : An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Unlike selective serotonin reuptake inhibitors (SSRIs), bupropion may be classified as a dual noradrenaline and dopamine reuptake inhibitor, a difference with potential implications for the treatment of residual sleepiness and fatigue in major depressive disorder (MDD)." | 9.19 | Resolution of sleepiness and fatigue: a comparison of bupropion and selective serotonin reuptake inhibitors in subjects with major depressive disorder achieving remission at doses approved in the European Union. ( Cooper, JA; Papakostas, GI; Tucker, VL, 2014) |
| "All patients were part of a smoking cessation program of the Nicotine Institute in collaboration with the general sick fund of Lower Austria." | 7.75 | Nocturnal sleep-disturbing nicotine craving and accomplishment with a smoking cessation program. ( Groman, E; Kunze, U; Riemerth, A, 2009) |
| " Each drug, besides its therapeutic effect, creates the risk of adverse reactions which number and severity is not always accepted by the patient." | 5.39 | [Safety of nicotine addiction treatment]. ( Cieślewicz, A; Jabłecka, A; Korzeniowska, K, 2013) |
| "Unlike selective serotonin reuptake inhibitors (SSRIs), bupropion may be classified as a dual noradrenaline and dopamine reuptake inhibitor, a difference with potential implications for the treatment of residual sleepiness and fatigue in major depressive disorder (MDD)." | 5.19 | Resolution of sleepiness and fatigue: a comparison of bupropion and selective serotonin reuptake inhibitors in subjects with major depressive disorder achieving remission at doses approved in the European Union. ( Cooper, JA; Papakostas, GI; Tucker, VL, 2014) |
| " Sleep disruption is the most common side effect observed with bupropion when used as an aid in smoking cessation." | 4.83 | [Cigarette smoking and sleep disturbance]. ( Meurice, JC; Paquereau, J; Underner, M, 2006) |
| "All patients were part of a smoking cessation program of the Nicotine Institute in collaboration with the general sick fund of Lower Austria." | 3.75 | Nocturnal sleep-disturbing nicotine craving and accomplishment with a smoking cessation program. ( Groman, E; Kunze, U; Riemerth, A, 2009) |
| " Each drug, besides its therapeutic effect, creates the risk of adverse reactions which number and severity is not always accepted by the patient." | 1.39 | [Safety of nicotine addiction treatment]. ( Cieślewicz, A; Jabłecka, A; Korzeniowska, K, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cooper, JA | 1 |
| Tucker, VL | 1 |
| Papakostas, GI | 1 |
| Korzeniowska, K | 1 |
| Cieślewicz, A | 1 |
| Jabłecka, A | 1 |
| Riemerth, A | 1 |
| Kunze, U | 1 |
| Groman, E | 1 |
| Underner, M | 1 |
| Paquereau, J | 1 |
| Meurice, JC | 1 |
| Balon, R | 1 |
| Thase, ME | 1 |
| Rye, DB | 1 |
| Dihenia, B | 1 |
| Bliwise, DL | 1 |
| Malek-Ahmadi, P | 1 |
2 reviews available for bupropion and Long Sleeper Syndrome
| Article | Year |
|---|---|
[Cigarette smoking and sleep disturbance].
Topics: Arousal; Bupropion; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Sleep; Sleep W | 2006 |
Depression, sleep, and antidepressants.
Topics: Adult; Antidepressive Agents; Bupropion; Circadian Rhythm; Comorbidity; Depressive Disorder; Electro | 1998 |
1 trial available for bupropion and Long Sleeper Syndrome
| Article | Year |
|---|---|
Resolution of sleepiness and fatigue: a comparison of bupropion and selective serotonin reuptake inhibitors in subjects with major depressive disorder achieving remission at doses approved in the European Union.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Depressive Disorder, Major; Double-Blind | 2014 |
5 other studies available for bupropion and Long Sleeper Syndrome
| Article | Year |
|---|---|
[Safety of nicotine addiction treatment].
Topics: Abdominal Pain; Adult; Alkaloids; Azocines; Benzazepines; Boredom; Bupropion; Female; Headache; Huma | 2013 |
Nocturnal sleep-disturbing nicotine craving and accomplishment with a smoking cessation program.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Behavior Therapy; Breath Tests; Bu | 2009 |
Bupropion and nightmares.
Topics: Antidepressive Agents, Second-Generation; Bipolar Disorder; Bupropion; Dreams; Female; Humans; Middl | 1996 |
Reversal of atypical depression, sleepiness, and REM-sleep propensity in narcolepsy with bupropion.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Depressive Disorder; Dopamine; Female; Humans; | 1998 |
Bupropion, periodic limb movement disorder, and ADHD.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Bupropion; Dopamine Uptake Inhibitors; Fe | 1999 |